AR230630A1 - Procedimiento para producir 5-(ciano o carbamil)-(3,4-bipiridin-6 1h-ona - Google Patents

Procedimiento para producir 5-(ciano o carbamil)-(3,4-bipiridin-6 1h-ona

Info

Publication number
AR230630A1
AR230630A1 AR284447A AR28444781A AR230630A1 AR 230630 A1 AR230630 A1 AR 230630A1 AR 284447 A AR284447 A AR 284447A AR 28444781 A AR28444781 A AR 28444781A AR 230630 A1 AR230630 A1 AR 230630A1
Authority
AR
Argentina
Prior art keywords
bipiridin
carbamil
ona
cyan
procedure
Prior art date
Application number
AR284447A
Other languages
English (en)
Spanish (es)
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Application granted granted Critical
Publication of AR230630A1 publication Critical patent/AR230630A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR284447A 1980-02-26 1981-02-26 Procedimiento para producir 5-(ciano o carbamil)-(3,4-bipiridin-6 1h-ona AR230630A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/124,808 US4264609A (en) 1980-02-26 1980-02-26 N-[3-Dimethylamino-2-(4-pyridinyl)-2-propenylidene]-N-methylmethaniminium chloride hydrochloride, its use in preparing 5-(cyano or carbamyl)-[3,4'-bipyridin]-6(1H)-one and its use as a cardiotonic

Publications (1)

Publication Number Publication Date
AR230630A1 true AR230630A1 (es) 1984-05-31

Family

ID=22416880

Family Applications (1)

Application Number Title Priority Date Filing Date
AR284447A AR230630A1 (es) 1980-02-26 1981-02-26 Procedimiento para producir 5-(ciano o carbamil)-(3,4-bipiridin-6 1h-ona

Country Status (28)

Country Link
US (1) US4264609A (de)
JP (1) JPS56128758A (de)
KR (2) KR840002067B1 (de)
AR (1) AR230630A1 (de)
AT (2) AT380237B (de)
AU (1) AU541644B2 (de)
BE (1) BE887663A (de)
CA (1) CA1128523A (de)
CH (1) CH647509A5 (de)
DE (1) DE3107306A1 (de)
DK (1) DK171253B1 (de)
ES (1) ES499776A1 (de)
FI (1) FI76787C (de)
FR (1) FR2476646A1 (de)
GB (1) GB2070600B (de)
HK (1) HK71789A (de)
IE (1) IE51696B1 (de)
IL (1) IL62161A (de)
IT (1) IT1210992B (de)
LU (1) LU83169A1 (de)
MX (1) MX6908E (de)
NL (1) NL192109C (de)
NO (1) NO156689C (de)
NZ (1) NZ196282A (de)
PH (2) PH19904A (de)
PT (1) PT72573B (de)
SE (2) SE437514B (de)
ZA (1) ZA811124B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200024B1 (de) 1985-04-30 1992-07-01 ARZNEIMITTELWERK DRESDEN GmbH 3-Cyan-pyridine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004012A (en) * 1975-10-14 1977-01-18 Sterling Drug Inc. 3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
AU6748781A (en) 1981-09-03
NZ196282A (en) 1983-12-16
IT8119952A0 (it) 1981-02-24
DK171253B1 (da) 1996-08-12
PH19904A (en) 1986-08-13
KR830005143A (ko) 1983-08-03
HK71789A (en) 1989-09-14
IE51696B1 (en) 1987-02-18
SE8402727D0 (sv) 1984-05-21
FI76787C (fi) 1988-12-12
IT1210992B (it) 1989-09-29
US4264609A (en) 1981-04-28
CH647509A5 (fr) 1985-01-31
CA1128523A (en) 1982-07-27
LU83169A1 (fr) 1981-09-11
PT72573B (en) 1982-02-12
DE3107306C2 (de) 1990-11-29
NO810639L (no) 1981-08-27
NO156689C (no) 1987-11-04
FI810582L (fi) 1981-08-27
NO156689B (no) 1987-07-27
SE452764B (sv) 1987-12-14
DK83981A (da) 1981-08-27
DE3107306A1 (de) 1981-12-17
BE887663A (fr) 1981-08-25
AT380236B (de) 1986-04-25
MX6908E (es) 1986-11-07
FR2476646B1 (de) 1984-08-17
NL192109B (nl) 1996-10-01
FR2476646A1 (fr) 1981-08-28
ES499776A1 (es) 1984-06-16
IE810397L (en) 1981-08-26
IL62161A0 (en) 1981-03-31
AT380237B (de) 1986-04-25
PH17145A (en) 1984-06-04
ATA305683A (de) 1985-09-15
GB2070600B (en) 1984-07-11
SE437514B (sv) 1985-03-04
PT72573A (pt) 1981-03-01
ATA88581A (de) 1985-09-15
NL8100922A (nl) 1981-09-16
SE8101205L (sv) 1981-08-27
ZA811124B (en) 1982-03-31
KR840002066B1 (ko) 1984-11-09
SE8402727L (sv) 1984-05-21
IL62161A (en) 1984-06-29
KR840002067B1 (ko) 1984-11-09
JPH0141626B2 (de) 1989-09-06
AU541644B2 (en) 1985-01-17
GB2070600A (en) 1981-09-09
NL192109C (nl) 1997-02-04
JPS56128758A (en) 1981-10-08
FI76787B (fi) 1988-08-31

Similar Documents

Publication Publication Date Title
DE3484782D1 (de) Neue 1,4-diketopyrrolo-(3,4-c)-pyrrole.
IT8024547A0 (it) Procedimento per la ossidrilazione di idrocarburi aromatici.
ES507960A0 (es) Un procedimiento para la mejoracion de 3-(pirid-3-0,4-ilalquil)indoles
DE3166949D1 (de) Antiinflammatory 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines
FI853255L (fi) Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.
DE3175317D1 (de) 5-(2,6-dichloro-4-trifluoromethyl-phenoxy)-2-nitrobenzaldehyde-diacetacylal
NO832803L (no) Fremgangsmaate for fremstilling av merkaptaner.
DK147300C (da) 24,24-difluor-25-hydroxy-6-alkoxy-3,5-cyclovitamin d3 forbindelser
RO84099A (ro) Procedeu pentru obtinerea 1,2,5-o0adiazol-2-o0izilor
ES507379A0 (es) Procedimiento para la preparacion de 1,2-dicloroetano.
AR228453A1 (es) Procedimiento para producir 2,3,5-tricloropiridina
AR230630A1 (es) Procedimiento para producir 5-(ciano o carbamil)-(3,4-bipiridin-6 1h-ona
NO812143L (no) Fremgangsmaate ved fremstilling av 6-hydrazon-pyrido(2,1-b)-kinazolin-11-oner
ES507706A0 (es) Procedimiento para la fabricacion de derivados de 5,6,7,7atetrahidro-4h-tieno(3,2-c)-piridin-2-ona .
NO841616L (no) Fremgangsmaate ved fremstilling av papir.
BR8103261A (pt) Processo para a preparacao de 4-amino-6-terc.butil-3-mercapto-1,2,4-triazin-5-ona
NO159250C (no) Fremgangsmaate ved fremstilling av jernbanehjul.
ES506792A0 (es) Procedimiento para la produccion de nuevos compuestos de lactama.
ES508259A0 (es) "procedimiento para preparar tiocarnitinas".
ES507200A0 (es) Procedimiento para la fabricacion de derivados de la 5,6,7.8-tetrahidro-1,6-naftiridina.
AR231640A1 (es) Procedimiento para preparar cicloalca 4,5 pirrolo 2,3-g-isoquinolinas
ATA185885A (de) Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols
ES525249A0 (es) Procedimiento para la obtencion de 1,3 tiazolidinas sustituidas.
IT1196108B (it) 3-(2,2,2-trisostituto idrazinio) propionati
ES512696A0 (es) "procedimiento de obtener compuestos metilquinoxalin-1,4-dioxidicos".